Pharmaceutical leaders are warning that the UK is becoming an unattractive destination for investment due to high and ...

UK pharma leaders warn excessive NHS levies threaten industry growth, urging the government to reform payments. The ABPI ...

Novo Nordisk A/S (NYSE:NVO) returned to full membership of the Association of the British Pharmaceutical Industry (ABPI) ...

The 21st century pharmaceutical and biotech ... The beginnings of the globalisation of the industry were seen both before and after the war – in the UK, import duties incentivised many foreign ...

As the pharmaceutical industry has operations and supply chains ... and avoid being confronted with data of less importance to you. Risk analysis for reshoring Whether as a result of deteriorating ...

Drug approvals by the US Food and Drug Administration fell more than 15% in 2024, but smaller pharmaceutical companies are ...

IPC Indice de Precios Y Cotizaciones 52,672.42-428.41-0.81% ...

The U.K. government is proposing to raise the rebate rate under a national drug cost program, drawing complaints from the Association of the British Pharmaceutical Industry (ABPI). As one of the ...

The UK pharmaceutical intermediate market is on a steady growth trajectory, expected to reach USD 1,156.0 million in 2025 and expand to USD 1,553.2 million by 2035, reflecting a compound annual growth ...

Register for this free strategy session today. The Association of the British Pharmaceutical Industry is the trade association for over 120 companies in the U.K. Also Read: Novo Nordisk's Combo ...

This was because the global pharmaceutical companies sought ... growth rate is positioning it as a future leader in the industry. An analysis report by B&K Securities said, “Indian CDMO ...